Wills Robert James
Insider CIK 1634189 · CBAY Director · GTXI Executive Chairman, Director · MIST Director · ACOG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACOG Alpha Cognition Inc. | P Buy | 2026-08-21 | 2026-08-24 | 10,000 | $9.62 | $96.2K | 32,241 | SEC↗ |
| ACOG Alpha Cognition Inc. | P Buy | 2026-08-21 | 2026-08-24 | 10,000 | $9.62 | $96.2K | 32,241 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| ACOG Alpha Cognition Inc. | A Award deriv | 2026-01-14 | 2026-01-16 | 8,437 | — | $0 | 8,437 | SEC↗ |
| ACOG Alpha Cognition Inc. | A Award | 2026-01-14 | 2026-01-16 | 7,241 | — | $0 | 22,241 | SEC↗ |
| ACOG Alpha Cognition Inc. | P Buy | 2025-08-18 | 2025-08-21 | 15,000 | $8.49 | $127.3K | 15,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2025-07-11 | 2025-07-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2025-07-11 | 2025-07-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award | 2025-07-11 | 2025-07-15 | 50,000 | — | $0 | 65,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ACOG Alpha Cognition Inc. | A Award deriv | 2025-04-07 | 2025-04-09 | 30,019 | — | $0 | 30,019 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2024-08-28 | 2024-08-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2024-04-08 | 2024-04-10 | 3,086 | $8.96 | $27.7K | 10,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2024-03-28 | 2024-04-01 | 6,914 | $8.48 | $58.6K | 6,914 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 16,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 9,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 27,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 15,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 7,500 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 18,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 27,705 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 49,245 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 32,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 30,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | S Sale | 2024-02-23 | 2024-02-27 | 980 | $9.04 | $8.9K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2023-06-07 | 2023-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | P Buy | 2022-10-19 | 2022-10-21 | 15,000 | $4.93 | $74.0K | 15,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2022-07-05 | 2022-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 67,000 | — | $0 | 67,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 32,000 | — | $0 | 32,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2020-10-01 | 2020-10-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 49,245 | — | $0 | 49,245 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 27,705 | — | $0 | 27,705 | SEC↗ |
| GTXI GTX INC /DE/ | P Buy | 2018-06-26 | 2018-06-26 | 5,000 | $16.75 | $83.8K | 137,344 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| GTXI GTX INC /DE/ | A Award deriv | 2018-01-01 | 2018-01-03 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-09-22 | 2017-09-26 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-08-01 | 2017-08-02 | 300 | $6.84 | $2.1K | 25,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-08-01 | 2017-08-02 | 200 | $6.83 | $1.4K | 25,200 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-08-01 | 2017-08-02 | 3,500 | $6.85 | $24.0K | 30,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-08-01 | 2017-08-02 | 1,000 | $6.84 | $6.8K | 26,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-06-28 | 2017-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-04-27 | 2017-05-01 | 27,000 | — | $0 | 27,000 | SEC↗ |
| GTXI GTX INC /DE/ | A Award deriv | 2017-02-28 | 2017-03-02 | 95,000 | — | $0 | 95,000 | SEC↗ |
| GTXI GTX INC /DE/ | A Award | 2016-10-14 | 2016-10-17 | 123,456 | $0.81 | $100.0K | 1,323,456 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2016-09-06 | 2016-09-09 | 25,000 | $2.43 | $60.8K | 25,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2016-06-28 | 2016-06-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| GTXI GTX INC /DE/ | P Buy | 2016-06-16 | 2016-06-20 | 100,000 | $0.65 | $65.0K | 1,200,000 | SEC↗ |
| GTXI GTX INC /DE/ | A Award deriv | 2016-01-01 | 2016-01-04 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2015-10-06 | 2015-10-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GTXI GTX INC /DE/ | P Buy | 2015-05-14 | 2015-05-14 | 36,440 | $0.98 | $35.7K | 100,000 | SEC↗ |
| GTXI GTX INC /DE/ | P Buy | 2015-05-13 | 2015-05-14 | 9,700 | $0.88 | $8.5K | 63,560 | SEC↗ |
| GTXI GTX INC /DE/ | P Buy | 2015-05-11 | 2015-05-13 | 3,860 | $0.80 | $3.1K | 53,860 | SEC↗ |
| GTXI GTX INC /DE/ | P Buy | 2015-05-08 | 2015-05-11 | 50,000 | $0.80 | $40.0K | 50,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2015-04-16 | 2015-04-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GTXI GTX INC /DE/ | A Award | 2015-03-02 | 2015-03-04 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |